Biohaven Pharmaceutical Holding Company Ltd. Common Shares (BHVN): Price and Financial Metrics
GET POWR RATINGS... FREE!
BHVN Stock Price Chart Interactive Chart >
BHVN Price/Volume Stats
| Current price | $19.34 | 52-week high | $20.07 |
| Prev. close | $18.82 | 52-week low | $5.54 |
| Day low | $19.01 | Volume | 42,130 |
| Day high | $19.84 | Avg. volume | 996,052 |
| 50-day MA | $15.99 | Dividend yield | N/A |
| 200-day MA | $0.00 | Market Cap | 1.32B |
Biohaven Pharmaceutical Holding Company Ltd. Common Shares (BHVN) Company Bio
Biohaven Pharmaceutical Holding Company Ltd., a clinical-stage biopharmaceutical company, develops product candidates to treat neurological diseases, including rare disorders. The company was founded in 2013 and is based in New Haven, Connecticut.
Latest BHVN News From Around the Web
Below are the latest news stories about BIOHAVEN LTD that investors may wish to consider to help them evaluate BHVN as an investment opportunity.
Do investors need to be concerned about Biohaven Ltd. (BHVN)?The share price of Biohaven Ltd. (NYSE:BHVN) rose to $19.20 per share on Monday from $18.44. While Biohaven Ltd. has overperformed by 4.12%, investors are advised to look at stock chart patterns for technical insight. On January 04, 2023, JP Morgan started tracking Biohaven Ltd. (NYSE: BHVN) recommending Overweight. A report published by BTIG Research […] |
Jim Cramer Says This Stock Up 23% In A Month Is ''A Great Speculative Buy''On CNBC’s "Mad Money Lightning Round," Jim Cramer said Biohaven Ltd (NYSE: BHVN ) is a "great speculative buy." Analysts agree, Benzinga data shows a consensus Overweight rating on BHVN. When asked about Boston Properties Inc (NYSE: … Full story available on Benzinga.com |
Biohaven to Present at the 41st Annual J.P. Morgan Healthcare ConferenceNEW HAVEN, Conn., Jan. 6, 2023 /PRNewswire/ -- Biohaven Ltd. (NYSE: BHVN) today announced that Vlad Coric, M.D., Chairman and Chief Executive Officer, will present at the 41st Annual J.P. Morgan Healthcare Conference at The Westin St. Francis Hotel in San Francisco, California, on… |
J.P. Morgan Says These 2 Stocks Are Ready to Rip Higher — This Is What Makes Them Attractive BuysWrapping up the first trading week of the New Year, it’s clear that last year’s headwinds haven’t left us. Inflation remains high, the Fed has signaled that it will keep interest rates higher, longer, in response, and negative economic indicators keep piling up, pointing toward an increased likelihood of recession. The challenge for investors hasn’t really changed: to build a portfolio that will pay, even in this difficult market environment. Times like this call for a guiding hand, perhaps some |
Is Biohaven Ltd. (BHVN) Outperforming Other Medical Stocks This Year?Here is how Biohaven Ltd. (BHVN) and Clover Health Investments, Corp. (CLOV) have performed compared to their sector so far this year. |
BHVN Price Returns
| 1-mo | 43.26% |
| 3-mo | 25.02% |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | -60.70% |
| 5-year | -39.68% |
| YTD | 39.34% |
| 2022 | -89.93% |
| 2021 | 60.79% |
| 2020 | 57.44% |
| 2019 | 47.21% |
| 2018 | 37.06% |
Loading social stream, please wait...